BMJ 1997;315:1235 (8 November)
Letters
Not all self help groups discourage sick doctors from being members
EditorI am glad to say that my encounters with the Manic-Depressive
Fellowship have been the reverse of N J Stafford's experience with a self help
group1: I have been warmly welcomed. I am currently
organising the fellowship's research papers and providing short abstracts of the medical
literature on manic depression. I have not come across the prejudice that Stafford describes and
am viewed as an asset because of my medical background.
I am also involved with the Doctors' Support Network.2 This is a self help organisation for doctors who have had significant
mental health problems. The focus is meeting with other doctors who have had similar problems,
in an environment where it feels safe to talk about these experiences. This group may be
contacted on 0171 727 3738 or through PO Box 12826, London SW4 8ZL.
Elizabeth Armstrong,
General
practitioner a
a 17 Broadwalk House, Hyde Park Gate, London SW7 5DZ
- Stafford NJ. How widespread is prejudice against sick
doctors . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
Women over 75 with fragility fractures should have DEXA
- Stuart H Ralston, Gina deLara, Donald J Farquhar, Stephen J Gallacher, Jim Hannan, and Alastair R McLellan
BMJ 2009 338: b2340.
[Extract]
[Full Text]
-
Terminally ill patients treated in the community should keep a copy of their records
- Jo Chambers
BMJ 1998 317: 283.
[Extract]
[Full Text]
-
Tolerability of alendronate
- Mike Kirby, John H Young, F Mackay, R D Mann, H Taggart, and R Kelly
BMJ 1998 316: 1389.
[Extract]
[Full Text]
-
Support and treatment of serious comorbidity also improve survival in breast cancer
- H W Nab and J W W Coebergh
BMJ 1997 315: 191.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Graham, D. Y., Malaty, H. M.
(2001). Alendronate and Naproxen Are Synergistic for Development of Gastric Ulcers. Arch Intern Med
161: 107-110
[Abstract]
[Full text]
-
Bauer, D. C., Black, D., Ensrud, K., Thompson, D., Hochberg, M., Nevitt, M., Musliner, T., Freedholm, D., for the Fracture Intervention Trial Research Group,
(2000). Upper Gastrointestinal Tract Safety Profile of Alendronate: The Fracture Intervention Trial. Arch Intern Med
160: 517-525
[Abstract]
[Full text]
-
Kirby, M., Young, J. H, Mackay, F, Mann, R D, Taggart, H, Kelly, R
(1998). Tolerability of alendronate. BMJ
316: 1389a-1389
[Full text]